Skip to main content
. 2022 Nov 2;13(4):649–669. doi: 10.1007/s13167-022-00300-6

Table 2.

Summary of DNA methylation markers in lung cancer early diagnosis

Single/combination marker Tumor type Sensitivity(%) Specificity(%) Sample type Reference

P16

RARB2

Lung cancer 69 87 Bronchial aspirates [36]
RASSF1A Lung cancer 64 100 Carcinoma tissues [79]
Lung cancer 60 90 Brushing sample
RASSF1A Lung cancer 92 100 Carcinoma tissues [80]
PCDHGB6 + HOXA9 Lung cancer 80 100 Brushing sample
RASSF1A NSCLC 87 75 Plasma(cirDNA) [81]
RARB2 Lung cancer
SHOX2 Squamous cell carcinoma 60 90 Plasma [82]
SHOX2 Lung cancer 68 95 Alveolar lavage fluid [83]
SHOX2 Lung cancer 65.5 90 Plasma [56]
PTGER4 Lung cancer 56.3 90
SHOX2 + PTGER4 Lung cancer 75.6 84.8
SHOX2 Lung cancer 67 90 Plasma [84]
PTGER4 Lung cancer 90 73
SHOX2 + RASSF1A Lung cancer 81 97.4 Bronchoalveolar lavage fluid [85]
HOXA9 NSCLC 55.2 74.3 Plasma [86]